With private equity bidders lined up, Sanofi's EU generics could go for up to $2.4B: Reuters
admin 6th February 2018 Uncategorised 0Sanofi has narrowed down the field of potential buyers for its generics business to drug companies from Brazil and India, plus several private equity funds, Reuters reports, citing sources. The deal could fetch $2.4 billion.
More: With private equity bidders lined up, Sanofi's EU generics could go for up to .4B: Reuters
Source: fierce